Cancer Therapeutics

Metabolically-fit Immunotherapies Portfolio

Pancratistatin Cyclic Phosphate Prodrugs and Phenpanstatin Cyclic Phosphate Prodrugs

Cyclodepsipeptide compounds presenting anti-cancer and anti-infective activity, and their synthesis

Tumor-Targeted Killing with Aptamer-Nucleic Acid Nanostructures

Carbohydrate-Mediated Tumor Targeting

Compounds to Modulate Retinoid X Receptors

QSOX1 as an anti-neoplastic drug target

Auristatin Tyramine Phosphate Prodrugs and Aminoquinoline Derivatives

Compounds to Modulate Retinoid X Receptors

Carbohydrate-Targeted Antitumor Agents